Researchers from the Departments of Cell Biology and Medical Physiology at the University of Seville have identified that a high expression of the human protein VRK1 is associated with tumor aggressiveness and low survival among neuroblastoma patients. Aggressive neuroblastoma is one of the most common solid childhood cancers and causes disproportionately high mortality in affected
Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life. Final recommendations from the National Institute for Health and Care Excellence (NICE) mean children over the age of 12 months, who have responded to previous treatment but have a high risk of their cancer coming back, will
A new study reveals that pediatric neuroblastoma patients are at elevated risk for long-term psychological impairment. In addition, those who experience such impairment as they get older tend to require special education services and to not go on to college. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok